The biopharmaceutical company will be delisted on July 5, less than three years after its admission to Euronext. Rothschild & Co's takeover bid was filed last week, with a view to delisting in September. Aptorum Group announced on Friday its delisting from Euronext Paris, due to insufficient liquidity. The departure...